期刊文献+

幽门螺杆菌感染与Barrett食管病变的相关性研究 被引量:6

Relation between Barrett esophagus and helicobacter pylori infection
下载PDF
导出
摘要 目的 探讨除幽门螺杆菌(Hp)感染和Barrett食管病变的关系.方法 收集168例内镜检查患者的病历资料,其中Barrett食管患者86例(Barrett食管组),胃食管反流病(GRRD)患者51例(GERD组),食管黏膜的正常患者31例(对照组),采用快速尿素酶法和Warthin Starry银染两种染色方法检测各组患者Hp感染状态.结果 对照组、GERD组和Barrett食管组Hp感染率分别为0、13.7%(7/51)和37.21%(32/86),Barrett食管组Hp感染率明显高于对照组和GERD组(X2=15.87,P〈0.01;X2=10.94,P〈0.01);Barrett食管中、重度炎症组Hp感染率明显高于轻度炎症组(X2=15.96,P〈0.01);特殊肠化组Barrett食管Hp感染率略低于胃底和贲门型组,差异无统计学意义(P〉0.05).结论 Hp感染与Barrett食管病变相关,Hp感染加重Barrett食管病变炎症程度. Objective To investigate the relation between Barrett esophagus(Barrett)and helicobacter pylori(Hp)infection.Methods One hundred and sixty eight patients were enrolled,including those affected by Barrett (n=86),gastreesophageal reflux disease(GERD n=51)and control group(n=31).Results The prevalence ofrate of Hp infection in Barrett was significantly higher than that in GERD control groups(X2=15.87.P〈0.01;X2=10.94,P〈0.01).The rate of Hp infection in the moderate and severe grade esophagitis was significantly higherthan that in the mild group(P〈0.01).r11lle rate of Hp infection in the Barrett with intestinal metaplasia was lowerthan that in the Barrett group,but no significant difference was found.Conclusion Hp infection plays an important role in Barrett and its inflammation grades.
出处 《中国医药》 2011年第7期802-803,共2页 China Medicine
关键词 幽门螺杆菌 BARRETT食管 胃食管反流病 Helicobacter pylori Barrett esophagus Gastroesophageal reflux disease
  • 相关文献

参考文献9

二级参考文献98

共引文献105

同被引文献76

  • 1高靖,欧阳建东,赵振涛,张晓野.Barrett食管的内镜表现及病理资料分析[J].现代医学,2008,36(4):290-292. 被引量:1
  • 2Ying Dong,Bing Qi,Xiao-Ying Feng,Chun-Meng Jiang.Meta-analysis of Barrett's esophagus in China[J].World Journal of Gastroenterology,2013,19(46):8770-8779. 被引量:7
  • 3Hunt RH,Xiao SD,Megraud F,Leon-Barua R,Bazzoli F,Van der Merwe S,vaz Coelho LG,Fock KM,Fedail S,Cohen H,Malfertheiner P,Vakil N,Hamid S,Goh KL,Wong BC,Krabshuis JH,杜颖,丛衍群,戴宁.世界胃肠病学组织(WGO-OMGE)临床指南——发展中国家幽门螺杆菌感染[J].胃肠病学,2007,12(1):40-52. 被引量:85
  • 4Kim SY, Jung SW. Helicobacter pylori Eradication Therapy in Korea[J]. Korean J. Gastroentero1,2011,58 (2) :67-73. 被引量:1
  • 5Malfertheiner P. Helicobacter pylori-a timeless source of lessons and research initiatives [J]. Helicobacter, 2007,2 : 85-89. 被引量:1
  • 6Chuah SK,Tsay FW,Hsu Pl,et al. A new look at anti-helicobacter pylori therapy [J]. World J Gastroenterololy, 2011,17 ( 35 ) : 3971-3975. 被引量:1
  • 7Park HG, Jung MK, Jung JT, et al. Randomised clinical trial : a comparative study of 10-day sequential therapy with 7-day standard triple therapy for helicobacter pylori infection in naive patients[J]. Aliment Pharmacol Ther,2012,35( 1 ) :56455. 被引量:1
  • 8Fakheri H, Taghvaei T, Hosseini V, et al. A comparison between sequential therapy and a modified bimuth-based quadruple therapy for helicobaeter pylori eradication in Iran:a randomized clinical trial[J]. Helicobacter,2012,17 ( 1 ) :43-48. 被引量:1
  • 9Graham DY, Lu H, Yamaoka Y. A report card to grade helicobacter pylori therapy [J]. Helicobaeter, 2007, 12 ( 4 ) : 275-278. 被引量:1
  • 10Vaira D, Zullo A, Vakil N, et al. Sequential therapy versus standard triple-drug therapy for helicobacter pylori eradication [J]. Annals of Internal Medicine,2007,146 ( 8 ) :556-563. 被引量:1

引证文献6

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部